John R. Barr is an Operating Partner of ACP, focused on investment opportunities in the medical device industry. John has spent his career in medical devices. From October 2014 to August 2017, John served as CEO at Surgical Specialties Inc., a privately held medical device firm specializing in wound closure and surgical knives. Prior to that he served as Executive Vice President and President of Global Surgical at Bausch & Lomb Holdings Incorporated until the acquisition of Bausch & Lomb by Valeant Pharmaceuticals in August 2013. In that role, he was responsible for the global medical device business including sales and development of disposables, equipment and instruments used in various forms of eye surgery. Prior to Bausch & Lomb, John was the Chief Executive Officer of AGA Medical Holdings. AGA Medical was a pioneer and leader in the development, sale and manufacture of disposable devices used in minimally invasive repair of structural heart and other vascular defects. John led an IPO for the Company in 2009 and the business was sold to St. Jude Medical in 2010.
He served as CEO of V.I. Technologies from November 1997 until July 2005 and led an IPO of the company in 1998. The mission of V.I. Technologies was to commercialize pathogen inactivation technology for transfusion blood products. Prior to V.I. Technologies he served as President of North American Operations and a member of the Board at Haemonetics Corp., where he had responsibility for Haemonetics’ blood bank, commercial plasma and blood bank services businesses.
He held various positions at Baxter Healthcare Corp., from July 1981 to April 1990. John is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master’s degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.
John is currently a member of the Board of EarlySense, LLC, a pioneer in the development of contactless monitoring for use in acute, sub-acute and home settings.